375 related articles for article (PubMed ID: 16823316)
101. Pathology of an experimental extradural spinal T cell tumor.
Kase CS; Wilborn WH; Varakis JN; Cheshire LB; Peterson RD
Lab Invest; 1982 May; 46(5):535-42. PubMed ID: 7078096
[TBL] [Abstract][Full Text] [Related]
102. Intramedullary canine spinal cord tumor model.
Salcman M; Botero E; Rao KC; Broadwell RD; Scott E
J Neurosurg; 1984 Oct; 61(4):761-6. PubMed ID: 6470788
[TBL] [Abstract][Full Text] [Related]
103. An unusual progression of benign thoracic spinal cord teratoma in pregnancy: a hormonally-mediated pathway?
Kumar V; Peng EW; Kurian KM; Smith C; Fitzpatrick MO; Whittle IR
Br J Neurosurg; 2006 Apr; 20(2):106-8. PubMed ID: 16753629
[TBL] [Abstract][Full Text] [Related]
104. An orthotopic murine model of human spinal metastasis: histological and functional correlations.
Tatsui CE; Lang FF; Gumin J; Suki D; Shinojima N; Rhines LD
J Neurosurg Spine; 2009 Jun; 10(6):501-12. PubMed ID: 19558282
[TBL] [Abstract][Full Text] [Related]
105. Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats.
Saini M; Bellinzona M; Meyer F; Cali G; Samii M
J Neurooncol; 1999 Mar; 42(1):59-67. PubMed ID: 10360479
[TBL] [Abstract][Full Text] [Related]
106. Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.
Ellis JA; Castelli M; Bruce JN; Canoll P; Ogden AT
Neurosurgery; 2012 Jan; 70(1):198-204; discussion 204. PubMed ID: 21760556
[TBL] [Abstract][Full Text] [Related]
107. Leptomeningeal spread of intramedullary spinal cord tumors. Report of three cases.
Bell WO; Packer RJ; Seigel KR; Rorke LB; Sutton LN; Bruce DA; Schut L
J Neurosurg; 1988 Aug; 69(2):295-300. PubMed ID: 3392575
[TBL] [Abstract][Full Text] [Related]
108. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma.
Kruse CA; Molleston MC; Parks EP; Schiltz PM; Kleinschmidt-DeMasters BK; Hickey WF
J Neurooncol; 1994; 22(3):191-200. PubMed ID: 7760095
[TBL] [Abstract][Full Text] [Related]
109. Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.
Yohay K; Tyler B; Weaver KD; Pardo AC; Gincel D; Blakeley J; Brem H; Rothstein JD
J Neurosurg; 2014 Apr; 120(4):854-63. PubMed ID: 24484234
[TBL] [Abstract][Full Text] [Related]
110. Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium.
Kimura H; Zhang L; Zhao M; Hayashi K; Tsuchiya H; Tomita K; Bouvet M; Wessels J; Hoffman RM
Cell Prolif; 2010 Feb; 43(1):41-8. PubMed ID: 19922490
[TBL] [Abstract][Full Text] [Related]
111. [Spinal drainage metastasis in cerebral glioblastoma/gliosarcoma].
Firsching R; Schröder R; Köning W; Frowein RA
Nervenarzt; 1985 Nov; 56(11):629-34. PubMed ID: 4080030
[No Abstract] [Full Text] [Related]
112. Progression of paralysis is the most useful factor for differentiating malignant from benign intramedullary tumors.
Ito T; Sawakami K; Ishikawa S; Hirano T; Endo N; Kakita A; Takahashi H
Spinal Cord; 2013 Apr; 51(4):319-21. PubMed ID: 23208538
[TBL] [Abstract][Full Text] [Related]
113. Effects of intramedullary injection of methiodal and lidocaine on spinal cords of dogs.
Parker AJ; Cusick PK; Stowater JL; Park RD
Am J Vet Res; 1975 Oct; 36(10):1529-32. PubMed ID: 171983
[TBL] [Abstract][Full Text] [Related]
114. Intramedullary spinal cord neoplasia in 53 dogs (1990-2010): distribution, clinicopathologic characteristics, and clinical behavior.
Pancotto TE; Rossmeisl JH; Zimmerman K; Robertson JL; Werre SR
J Vet Intern Med; 2013; 27(6):1500-8. PubMed ID: 24010541
[TBL] [Abstract][Full Text] [Related]
115. [Rheography of the open spinal cord in primary tumors].
Okladnikov GI
Zh Vopr Neirokhir Im N N Burdenko; 1987; (3):34-9. PubMed ID: 3630510
[TBL] [Abstract][Full Text] [Related]
116. "Primary" spinal intramedullary lymphomas: a review.
Hautzer NW; Aiyesimoju A; Robitaille Y
Ann Neurol; 1983 Jul; 14(1):62-6. PubMed ID: 6614871
[TBL] [Abstract][Full Text] [Related]
117. Lentiviral Vector Induced Modeling of High-Grade Spinal Cord Glioma in Minipigs.
Tora MS; Texakalidis P; Neill S; Wetzel J; Rindler RS; Hardcastle N; Nagarajan PP; Krasnopeyev A; Roach C; James R; Bruce JN; Canoll P; Federici T; Oshinski JN; Boulis NM
Sci Rep; 2020 Mar; 10(1):5291. PubMed ID: 32210315
[TBL] [Abstract][Full Text] [Related]
118. Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
Maria BL; Gupta N; Gilg AG; Abdel-Wahab M; Leonard AP; Slomiany M; Wheeler WG; Tolliver LB; Babcock MA; Lucas JT; Toole BP
J Child Neurol; 2008 Oct; 23(10):1214-20. PubMed ID: 18952588
[TBL] [Abstract][Full Text] [Related]
119. Seldom-segment versus multi-segment intramedullary spinal cord gliomas: a comparative clinical study.
Sun J; Wang Z; Li Z; Wu H; Zheng M; Chang Q; Han Y; Cui Z; Liao HI; Wang T; Chen X; Yang X; Yang J
Sci China Life Sci; 2019 Jun; 62(6):862-864. PubMed ID: 30539336
[No Abstract] [Full Text] [Related]
120. A color-coded orthotopic nude-mouse treatment model of brain-metastatic paralyzing spinal cord cancer that induces angiogenesis and neurogenesis.
Hayashi K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Bouvet M; Wessels J; Hoffman RM
Cell Prolif; 2009 Feb; 42(1):75-82. PubMed ID: 19143765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
